Composition of Acellular Dermal Matrix (ADM)
Acellular dermal matrix (ADM) is primarily made of decellularized dermal tissue that has been processed to remove DNA and antigenic donor cells while preserving the extracellular matrix components including collagen, fibronectin, elastin, laminin, glycosaminoglycans, and hyaluronic acid. 1
Source Materials
ADMs are derived from two main sources:
- Allogenic (human): Processed from cadaveric human skin 2, 3
- Xenogenic (animal): Derived from mammalian sources, typically:
- Porcine (pig) dermal tissues
- Bovine (cow) dermal tissues 1
Processing and Structure
The manufacturing of ADM involves several key processes:
Decellularization: Removal of cellular components and DNA to create an immunologically inert scaffold 3
Cross-linking variations: ADMs are divided into two subgroups based on processing:
Sterilization: Available in either aseptic or sterile forms 2
Structural Components
The preserved extracellular matrix in ADM includes:
- Basement membrane: Provides structural foundation
- Dermal layer: Rich in collagen that serves as a scaffold
- Growth factors: Essential for supporting wound healing 4
Biological Function
ADM functions as a biological scaffold that:
Supports cell infiltration: Provides a framework for host fibroblasts to migrate into the matrix
Promotes vascularization: Facilitates blood vessel formation and integration
Enables tissue remodeling: Gradually becomes incorporated into the recipient's own tissue 3, 1
Supports epithelialization: Provides a platform for mucosal epithelization in certain applications 4
Clinical Considerations
When selecting an ADM for clinical use, important factors include:
Storage requirements: Some require specific temperature conditions
Rehydration needs: Preparation may involve rehydration steps
Thickness and size options: Available in various dimensions for different applications 2
Cost implications: ADMs are generally expensive, which may limit their use in certain clinical scenarios 1
It's important to note that while ADMs offer significant advantages in terms of reducing donor site morbidity and providing structural support, their long-term durability is still being evaluated in clinical studies 2.
Human Acellular Dermal Matrix (ADM) is particularly notable for its low infection rates (1.6%) when used in emergency repair of abdominal wall hernias, though recurrence rates of approximately 15.9% have been reported in longer-term follow-up 2.